Predictive Oncology Platform and Utility Protocols (Q11677): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
Plate-forme d’oncologie prédictive et protocoles utilitaires | |||
Revision as of 09:18, 28 November 2021
Project Q11677 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Predictive Oncology Platform and Utility Protocols |
Project Q11677 in Czech Republic |
Statements
39,804,511.31 Czech koruna
0 references
61,769,881.0 Czech koruna
0 references
64.44 percent
0 references
31 October 2020
0 references
Institute of Applied Biotechnologies a.s.
0 references
50°5'1.93"N, 14°30'28.48"E
0 references
10800
0 references
10800
0 references
Jedná se o projekt vysoké technologické úrovně a vysoké míry inovace, který si klade za cíl významně zvýšit produktový potenciál společnosti Institute of Applied Biotechnologies a.s. (IAB) ve spolupráci s výzkumným partnerem Lékařskou fakultou Univerzity Palackého v Olomouci, jmenovitě Ústavem molekulární a translační medicíny (UMTM). Cílem je vývoj produktů pro prediktivní onkologickou diagnostiku založenou na cirkulujících buňkách / DNA / RNA. a. (Czech)
0 references
It is a project of high technological level and high degree of innovation, which aims to significantly increase the product potential of the Institute of Applied Biotechnologies a.s. (IAB) in cooperation with a research partner of the Faculty of Medicine of Palacký University in Olomouc, namely the Institute of Molecular and Translational Medicine (UMTM). The aim is to develop products for predictive oncological diagnostics based on circulating cells/DNA/RNA. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_107/0012422
0 references